We further examined the clinical relevance of CREB3L2 expression by analyzing three separate HCC patient dataset from the GEO (Fig. 1B), the results also verify that the expression of CREB3L2 is sustainedly markedly upregulated in HCC tumor samples compared to adjacent non-tumor tissues. Here, CREB3L2 is linked to hepatocellular carcinoma.